Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cluster of differentiation 24 (CD24) is a glycosylated protein implicated in cancer progression.
• CD24 overexpression is observed in various cancer types and cancer stem cells.
• Its precise role in cancer development, invasion, and metastasis requires further elucidation.

Purpose of the Study:

• To compile and review the known cancer-related mechanisms involving CD24.
• To highlight the signaling pathways dysregulated by CD24 in cancer cells.
• To provide insights for developing novel CD24-targeted cancer therapies.

Main Methods:

• Literature review of studies investigating CD24 function in cancer.
• Analysis of CD24's involvement in various cellular signaling pathways.
• Compilation of evidence linking CD24 to cancer cell proliferation, invasion, and metastasis.

Main Results:

• CD24 dysregulates signaling pathways including Src kinases, STAT3, EGFR, Wnt/β-catenin, and MAPK.
• CD24 activates p38 MAPK and STAT3 via Src kinases.
• Downstream effectors of CD24-activated EGFR, such as Akt and ERK, promote cancer cell invasion and metastasis.
• CD24 upregulates HER2 expression through NF-κB activation and miR-21 oncomir expression via Src kinases.

Conclusions:

• CD24 plays a significant role in cancer progression through the modulation of multiple signaling pathways.
• Detailed understanding of CD24-associated pathways can lead to the development of new therapeutic strategies.
• Targeting CD24 presents a promising avenue for future cancer treatments.